A detailed history of Principal Securities, Inc. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 957 shares of CRBU stock, worth $2,670. This represents 0.0% of its overall portfolio holdings.

Number of Shares
957
Previous 614 55.86%
Holding current value
$2,670
Previous $1.01 Million 86.3%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$1.56 - $2.73 $535 - $936
343 Added 55.86%
957 $1.88 Million
Q2 2024

Jul 31, 2024

SELL
$1.62 - $5.05 $30 - $95
-19 Reduced 3.0%
614 $1.01 Million
Q1 2024

May 10, 2024

SELL
$4.82 - $8.26 $245 - $421
-51 Reduced 7.46%
633 $3.25 Million
Q4 2023

Feb 07, 2024

BUY
$3.58 - $6.25 $2,448 - $4,275
684 New
684 $3.92 Million

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $170M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.